药物发现信息学市场增长、规模、份额、趋势、关键参与者分析及 2031 年预测

  • Report Code : TIPHE100000965
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Drug Discovery Informatics Market to 2031 - Growth and Trends

Buy Now

【研究报告】2023年药物发现信息学市场估值为30.7亿美元,预计到2031年将达到81.7亿美元;预计 2023 年至 2031 年复合年增长率为 13.0%。

市场洞察和分析师观点:

药物发现信息学市场预测是根据各种二级和二级研究结果得出的。主要研究来源。

药物发现信息学是一个将计算和信息科学与化学和生物学相结合的领域。它使用各种计算工具、算法和数据库来研究和解释大量的生物和化学数据。通过利用信息学的力量,研究人员可以加快药物发现过程,从而更有效、更经济地识别潜在的候选药物。因此,信息学工具的采用正在促进药物发现信息学市场规模的不断增长。

影响药物发现信息学市场增长的驱动因素

制药和生物制药行业在研发方面投入巨资,以开发新产品和拓展免疫学、癌症、传染病等领域的产品管线。例如,许多创新制药公司现在正在投资基因组学,以重新激发药物发现的活力。根据《精准医学杂志》2021 年 3 月发表的文章,阿斯利康启动了一个对 200 万个基因组进行测序的项目,这是一项旨在在未来十年收集基因组序列和健康记录的大规模举措。同一消息人士进一步表示,葛兰素史克投资 40 英镑(4248 美元)扩大与英国生物银行的合作关系。这项投资支持对 500,000 人进行测序,生成独特且丰富的匿名且安全的数据资源。领先的制药公司不再采购数据,而是利用富含基因组、表型和临床数据的人群数据集。因此,对药物发现活动的投资不断增加正在推动药物发现信息学市场的增长。



报告细分和范围:

“全球药物发现” 《2031 年信息学市场分析》是一项专门且深入的研究,重点关注全球市场动态,以帮助确定关键驱动因素、未来趋势和利润丰厚的机会,从而有助于确定主要收入来源。该报告旨在提供市场概览,并按工作流程、服务、解决方案和最终用户进行详细的市场细分。药物发现信息学市场报告的范围涉及北美(美国、加拿大和墨西哥)、欧洲(西班牙、英国、德国、法国、意大利和欧洲其他地区)、亚太地区(韩国、中国、印度、日本、澳大利亚和亚太其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。

细分分析:

根据工作流程,市场分为发现信息学和药物开发。发现信息学领域在 2023 年占据更大的市场份额。预计药物开发领域从 2023 年到 2031 年将实现更高的复合年增长率。

市场按服务细分为序列分析平台、分子建模、临床试验数据管理、对接等。序列分析平台领域预计将在 2023 年占据最大的药物发现信息学市场份额。分子建模领域预计将在 2023 年至 2031 年实现最高的复合年增长率。

通过解决方案,药物发现信息学市场是细分为软件和服务。服务细分市场将在 2023 年占据更大的市场份额,预计 2023 年至 2031 年该细分市场的复合年增长率将更高。

按解决方案划分的药物发现信息学市场 - 2023 年和 2031 年

基于在最终用户方面,市场分为制药和生物技术公司、合同研究组织等。制药和生物技术公司细分市场在 2023 年占据最大市场份额。合同研究组织细分市场预计 2023 年至 2031 年复合年增长率最高。

区域展望:

北美2023 年,美国占据最大的药物发现信息学市场份额。2023 年,美国占据最大的市场份额,其次是加拿大。这是由于 Charles River Laboratories、Certara 和 Curia 等主要参与者的存在、传染病的高发率以及领先制药公司和合同研究组织 (CRO) 快速采用新的先进研发工具等因素造成的。 )用于药物发现和开发。这些公司越来越注重合资企业和研究合作,预计这将进一步推动该地区的市场增长。例如,2022 年 8 月,Atomwise 与赛诺菲建立了战略性多目标研究合作,以进行人工智能驱动的药物发现。此次合作将重点利用该公司的 AtomNet 平台开发多达五个药物靶标,作为其计算发现和研究工作的一部分。

行业发展和未来机遇:

根据公司新闻稿,下面列出了全球药物发现信息学市场主要参与者采取的一些举措:

2024 年 1 月,Evotec 与克罗恩病和结肠炎基金会合作开发炎症性肠病 (IBD) 的新疗法)。根据这一合作伙伴关系,两家公司将利用 Evotec 的综合研发平台推进两个创新药物靶标的药物发现,以解决纤维化和肠道屏障功能受损问题。 2023 年 11 月,Certara 推出了 Simcyp Biopharmaceutics 软件,旨在提高研发效率新药和仿制药的配方开发。 Simcyp Biopharmaceutics 软件旨在帮助生物制药、制剂和科学家快速、经济高效地配制复杂、新颖和通用的小分子药物。 2022 年 6 月,Chemical.AI 和 Chemaxon 宣布合作,整合他们的科学技术信息学软件。著名人工智能 (AI) 公司 Chemical.AI 宣布与领先的化学和生物软件开发公司 Chemaxon 建立战略合作伙伴关系。此次合作允许最终用户选择访问 Chemaxon 的设计中心和 Chemical.AI 的 ChemAIRS。 2022 年 4 月,Certara, Inc. 和 Chemaxon 建立了战略合作伙伴关系,以实现药物研究现代化。该合作伙伴关系提供了科学信息学工作流程之间的互连性。 Certara 的科学信息学软件将与 Chemaxon 的设计中心无缝连接,为用户提供分析和复合设计。此次联合开发建立在 Certara 和 Chemaxon 产品之间的集成之上,例如 JChem 化学盒、MarvinSketch 和 JChem for Office。竞争格局和主要公司:

Certara;印孚瑟斯有限公司;协作药物发现公司;欣欣向荣的生物系统公司;库里亚全球公司;凯麦克森有限公司;查尔斯河实验室;安捷伦科技公司;照明公司;勃林格殷格翰国际有限公司;和 Evotec 是药物发现信息学市场报告中介绍的知名公司之一。这些公司专注于新技术、现有产品的进步和地域扩张,以满足全球不断增长的消费者需求。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is drug discovery informatics?

Drug discovery informatics is a field that integrates computational and information sciences with chemistry and biology. It uses various computational tools, algorithms, and databases to study and interpret vast volumes of biological and chemical data.

Who are the major players in the drug discovery informatics?

The drug discovery informatics majorly consists of the players, including Certara; Infosys Ltd.; Collaborative Drug Discovery, Inc.; Jubliant Biosys; Curia Global, Inc.; Chemaxon Ltd; Charles River Laboratories; Agilent Technologies, Inc.; Illumina, Inc; Boehringer Ingelheim International GmbH; and Evotec.

What factors drive the drug discovery informatics?

Key factors driving the drug discovery informatics growth are the increasing investments in the R&D of new drug molecules by pharmaceutical companies and the growing adoption of computational and information tools for drug discovery and development.

Which type segment dominates the drug discovery informatics?

The drug discovery informatics market, by workflow, is bifurcated into discovery informatics and drug development. The discovery informatics segment held a larger market share in 2023.

What was the estimated drug discovery informatics size in 2023?

The drug discovery informatics was valued at US$ 3.073billion in 2023.

What are the growth estimates for the drug discovery informatics till 2031?

The drug discovery informatics is expected to be valued at US$ 8.17 billion in 2031.

The List of Companies - Drug Discovery Informatics Market

  1. Certara
  2.  Infosys Ltd.
  3.  Collaborative Drug Discovery, Inc.
  4.  Jubliant Biosys
  5. Curia Global, Inc.
  6. Chemaxon Ltd
  7. Charles River Laboratories
  8. Agilent Technologies, Inc.
  9. Illumina, Inc
  10. Boehringer Ingelheim International GmbH

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..